Filing Details
- Accession Number:
- 0001567619-18-004474
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-10-24 16:25:26
- Reporting Period:
- 2018-10-17
- Accepted Time:
- 2018-10-24 16:25:26
- Original Submission Date:
- 2018-10-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-17 | 314 | $63.50 | 29,253 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- This form 4/A is being filed to amend the sales price of the shares.
Billionaire Hedge Funds
